三阴性乳腺癌的临床试验
总计2499个结果
-
German Breast GroupAstraZeneca; Celgene完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul Cancro终止
-
University of VirginiaCelldex Therapeutics撤销
-
Hoffmann-La Roche完全的
-
Genentech, Inc.Hoffmann-La Roche完全的
-
Istituti Ospitalieri di Cremona未知
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology Commission主动,不招人三阴性乳腺癌
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University; The Affiliated... 和其他合作者完全的
-
Piramal Enterprises Limited终止
-
Alison Stopeck招聘中
-
National Cancer Institute (NCI)终止乳腺癌 | 转移性乳腺癌 | 三阴性乳腺癌 | 激素受体阴性乳腺癌 | HER2+ 乳腺癌美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人炎性乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性美国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...招聘中
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘乳腺癌 | 三阴性乳腺癌
-
Hoffmann-La Roche招聘中乳腺癌大韩民国, 美国, 以色列, 丹麦, 阿根廷, 墨西哥, 巴西, 德国, 秘鲁, 波兰, 西班牙, 台湾, 南非, 捷克语, 意大利, 澳大利亚, 匈牙利
-
Vastra Gotaland RegionLund University; Sahlgrenska University Hospital, Sweden尚未招聘
-
Gilead SciencesAlliance Foundation Trials, LLC.; NSABP Foundation Inc招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC招聘中
-
Fudan UniversityMerck Sharp & Dohme LLC招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Bryan Schneider, MDPfizer; Genentech, Inc.; Indiana University; Foundation Medicine; Vera Bradley Foundation for Breast...招聘中
-
First Affiliated Hospital, Sun Yat-Sen University尚未招聘
-
Institut Cancerologie de l'OuestTelix Pharmaceutical; SIRIC ILIAD招聘中
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.招聘中